Literature DB >> 17600114

Implementation of an emergency department based transient ischemic attack clinical pathway: a pilot study in knowledge translation.

Michael D Brown1, Mathew J Reeves, Ted Glynn, Arshad Majid, Rashmi U Kothari.   

Abstract

OBJECTIVES: To assess the feasibility of implementing an emergency department (ED)-based transient ischemic attack (TIA) clinical pathway that uses computer-based clinical support, and to evaluate measures of quality, safety, and efficiency.
METHODS: This was a prospective cohort study of adult patients presenting to a community ED with symptoms consistent with acute TIA. Adherence to the clinical pathway served as a test of feasibility. Compliance with guideline recommendations for antithrombotic therapy and vascular imaging were used as process measures of quality. The 90-day risk of recurrent TIA, stroke, or death provided estimates of safety. Efficiency was assessed by measuring the rate of uneventful hospitalization, defined as a hospital admission that did not result in any major medical event or vascular intervention such as endarterectomy or stent placement.
RESULTS: Of the 75 subjects enrolled, physician adherence to the clinical pathway was 85.3%, and 35 patients (46.7%) were discharged home from the ED. Antithrombotic agents were prescribed to 68 (90.7%), and vascular imaging was performed in 70 (93.3%). The 90-day risk of recurrent TIA was seven out of 75 (9.3%; 95% confidence interval [CI] = 4.6% to 18.0%), one patient experienced stroke (1.3%; 95% CI = 0.2% to 7.2%), and three patients died (4.0%; 95% CI = 1.4% to 11.1%). Uneventful hospitalization occurred in 38 of 40 patients (95.0%).
CONCLUSIONS: Implementation of a clinical pathway for the evaluation and management of TIA using computer-based clinical support is feasible in a community ED setting. This pilot study in knowledge translation provides a design framework for further studies to assess the safety and efficiency of a structured ED-based TIA clinical pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600114     DOI: 10.1197/j.aem.2007.04.019

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  5 in total

1.  An assessment of the incremental value of the ABCD2 score in the emergency department evaluation of transient ischemic attack.

Authors:  Latha G Stead; Smitha Suravaram; M Fernanda Bellolio; Sailaja Enduri; Alejandro Rabinstein; Rachel M Gilmore; Anjali Bhagra; Veena Manivannan; Wyatt W Decker
Journal:  Ann Emerg Med       Date:  2010-09-19       Impact factor: 5.721

2.  Effectiveness of a Multidisciplinary Clinical Pathway for Elderly Patients With Hip Fracture: A Multicenter Comparative Cohort Study.

Authors:  P H S Kalmet; B B Koc; B Hemmes; R H M Ten Broeke; G Dekkers; P Hustinx; M G Schotanus; P Tilman; H M J Janzing; J M A Verkeyn; P R G Brink; M Poeze
Journal:  Geriatr Orthop Surg Rehabil       Date:  2016-05-02

3.  An International Report on the Adaptations of Rapid Transient Ischaemic Attack Pathways During the COVID-19 Pandemic.

Authors:  Andy Lim; Shaloo Singhal; Philippa Lavallee; Pierre Amarenco; Peter M Rothwell; Gregory Albers; Mukul Sharma; Robert Brown; Annemarei Ranta; Mohana Maddula; Timothy Kleinig; Jesse Dawson; Mitchell S V Elkind; Maria Guarino; Shelagh B Coutts; Benjamin Clissold; Henry Ma; Thanh Phan
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-08-18       Impact factor: 2.136

4.  Long-term Patient-reported Quality of Life and Pain After a Multidisciplinary Clinical Pathway for Elderly Patients With Hip Fracture: A Retrospective Comparative Cohort Study.

Authors:  Pishtiwan H S Kalmet; Stijn G C J de Joode; Audrey A A Fiddelers; Rene H M Ten Broeke; Martijn Poeze; Taco Blokhuis
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-06-06

Review 5.  The role of Decision Support System (DSS) in prevention of cardiovascular disease: a systematic review and meta-analysis.

Authors:  Raghupathy Anchala; Maria P Pinto; Amir Shroufi; Rajiv Chowdhury; Jean Sanderson; Laura Johnson; Patricia Blanco; Dorairaj Prabhakaran; Oscar H Franco
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.